Global epidemiology of liver cancer burden due to hepatitis B virus: A comprehensive estimate based on Global Burden of Disease Study 2021
The global burden of HBV-related liver cancer showed significant regional disparities and presented ongoing global health challenges. Socioeconomic factors and healthcare access are closely associated with disease burden. Effective, region-specific interventions are essential to mitigate future HBV-related liver cancer burdens.
Authors
- Qianru Li (ORCID: https://orcid.org/0009-0006-4379-2337)
- Jiachen Wang (ORCID: https://orcid.org/0000-0003-3170-453X)
- Changfa Xia (ORCID: https://orcid.org/0000-0001-9097-1369)
- Yuanjie Zheng (ORCID: https://orcid.org/0009-0001-9576-1106)
- Yi Teng
- Nuopei Tan (ORCID: https://orcid.org/0000-0001-5173-0458)
- Tingting Zuo (ORCID: https://orcid.org/0000-0003-2813-7474)
- Mengdi Cao
- Wanqing Chen (ORCID: https://orcid.org/0000-0002-1159-1884)
- Tianyi Li (ORCID: https://orcid.org/0000-0002-4654-9862)
- Jinhui Zhou (ORCID: https://orcid.org/0009-0000-1743-9595)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Chinese Medical Journal
- Published
- 2025-10-31
- DOI
- https://doi.org/10.1097/cm9.0000000000003787
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00